BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35713962)

  • 1. Vaccination and modern management of chronic obstructive pulmonary disease - a narrative review.
    Joean O; Welte T
    Expert Rev Respir Med; 2022 Jun; 16(6):605-614. PubMed ID: 35713962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized medicine and chronic obstructive pulmonary disease.
    Wouters EF; Wouters BB; Augustin IM; Franssen FM
    Curr Opin Pulm Med; 2017 May; 23(3):241-246. PubMed ID: 28257315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management.
    Woodruff PG; Agusti A; Roche N; Singh D; Martinez FJ
    Lancet; 2015 May; 385(9979):1789-1798. PubMed ID: 25943943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What does endotyping mean for treatment in chronic obstructive pulmonary disease?
    Agustí A; Celli B; Faner R
    Lancet; 2017 Sep; 390(10098):980-987. PubMed ID: 28872030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in chronic obstructive pulmonary disease pathogenesis: from disease mechanisms to precision medicine.
    Brandsma CA; Van den Berge M; Hackett TL; Brusselle G; Timens W
    J Pathol; 2020 Apr; 250(5):624-635. PubMed ID: 31691283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic obstructive pulmonary disease - diagnosis and management of stable disease; a personalized approach to care, using the treatable traits concept based on clinical phenotypes. Position paper of the Czech Pneumological and Phthisiological Society.
    Zatloukal J; Brat K; Neumannova K; Volakova E; Hejduk K; Kocova E; Kudela O; Kopecky M; Plutinsky M; Koblizek V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Dec; 164(4):325-356. PubMed ID: 33325455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.
    Singh D; Roche N; Halpin D; Agusti A; Wedzicha JA; Martinez FJ
    Am J Respir Crit Care Med; 2016 Sep; 194(5):541-9. PubMed ID: 27585383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COPD and biologic treatment: state of the art.
    Ferri S; Paoletti G; Pelaia C; Heffler E; Canonica GW; Puggioni F
    Curr Opin Allergy Clin Immunol; 2023 Aug; 23(4):309-318. PubMed ID: 37357768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precision Approaches to Chronic Obstructive Pulmonary Disease Management.
    Moll M; Silverman EK
    Annu Rev Med; 2024 Jan; 75():247-262. PubMed ID: 37827193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory Endotype-Associated Airway Resistome in Chronic Obstructive Pulmonary Disease.
    Yi X; Li Y; Liu H; Liu X; Yang J; Gao J; Yang Y; Liang Z; Wang F; Chen D; Wang L; Shi W; Lam DCL; Stampfli MR; Jones PW; Chen R; Wang Z
    Microbiol Spectr; 2022 Apr; 10(2):e0259321. PubMed ID: 35311590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demystification of artificial intelligence for respiratory clinicians managing patients with obstructive lung diseases.
    Antão J; de Mast J; Marques A; Franssen FME; Spruit MA; Deng Q
    Expert Rev Respir Med; 2023 Dec; 17(12):1207-1219. PubMed ID: 38270524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global Initiative for Chronic Obstructive Lung Disease strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: an Asia-Pacific perspective.
    Asia Pacific COPD Roundtable Group
    Respirology; 2005 Jan; 10(1):9-17. PubMed ID: 15691232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions to Increase the Rate of Influenza and Pneumococcal Vaccination in Patients with Chronic Obstructive Pulmonary Disease: A Scoping Review.
    Trethewey SP; Patel N; Turner AM
    Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31208087
    [No Abstract]   [Full Text] [Related]  

  • 14. Recommendations for COPD management in Central and Eastern Europe.
    Valipour A; Aisanov Z; Avdeev S; Koblizek V; Kocan I; Kopitovic I; Lupkovics G; Man M; Bukovskis M; Tudoric N; Vukoja M; Naumnik W; Yanev N
    Expert Rev Respir Med; 2022 Feb; 16(2):221-234. PubMed ID: 35001780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Chronic obstructive pulmonary disease and phenotypes: a state-of-the-art.".
    Corlateanu A; Mendez Y; Wang Y; Garnica RJA; Botnaru V; Siafakas N
    Pulmonology; 2020; 26(2):95-100. PubMed ID: 31740261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarker Development for Chronic Obstructive Pulmonary Disease. From Discovery to Clinical Implementation.
    Sin DD; Hollander Z; DeMarco ML; McManus BM; Ng RT
    Am J Respir Crit Care Med; 2015 Nov; 192(10):1162-70. PubMed ID: 26176936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of the current management of chronic obstructive pulmonary disease: can we go beyond the GOLD recommendations?
    Cazzola M; Rogliani P; Puxeddu E; Ora J; Matera MG
    Expert Rev Respir Med; 2018 Jan; 12(1):43-54. PubMed ID: 29082808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Focus on influenza vaccination in patients with chronic obstructive pulmonary disease].
    Sun YC
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Apr; 45(4):333-334. PubMed ID: 35381628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Chronic Obstructive Pulmonary Disease Phenotypes, Endotypes, and Biomarkers.
    Garudadri S; Woodruff PG
    Ann Am Thorac Soc; 2018 Dec; 15(Suppl 4):S234-S238. PubMed ID: 30758998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease phenotyping in chronic obstructive pulmonary disease: the neutrophilic endotype.
    Russell DW; Wells JM; Blalock JE
    Curr Opin Pulm Med; 2016 Mar; 22(2):91-9. PubMed ID: 26717512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.